Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. - Cabiedes, J; Cabral, AR; Alarcon-Segovia, D (J Rheumatol, 1995)